Provided by Tiger Fintech (Singapore) Pte. Ltd.

ABVC BioPharma, Inc.

0.8729
+0.01792.09%
Volume:177.56K
Turnover:149.83K
Market Cap:13.14M
PE:-2.08
High:0.8963
Open:0.8550
Low:0.8200
Close:0.8550
Loading ...

Company Profile

Company Name:
ABVC BioPharma, Inc.
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
18
Office Location:
44370 Old Warm Springs Boulevard,Fremont,California,United States
Zip Code:
94538
Fax:
- -
Introduction:
ABVC BioPharma, Inc., a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase II clinical trials a combination therapy for triple negative breast cancer; ABV-1504 has completed Phase II clinical trials for major depressive disorders; ABV-1505, which is in Phase II clinical trials for adult attention deficit hyperactivity disorder; ABV-1703, which is in Phase II clinical trials for the treatment of metastatic pancreatic cancer; ABV-1702, which is in Phase II clinical trials to treat myelodysplastic syndromes; ABV-1601 that is in Phase I/II clinical trials for treating depression in cancer patients; ABV-1701 Vitargus that is in Phase II clinical trials for the treatment of retinal detachment or vitreous hemorrhage; and ABV-1519, which is in Phase I/II clinical trials for the treatment of non-small cell lung cancer. ABVC BioPharma, Inc. has a co-development agreement with Rgene Corporation; and collaboration agreements with BioHopeKing Corporation and BioFirst Corporation. The company is based in Fremont, California. ABVC BioPharma, Inc. is a subsidiary of YuanGene Corporation.

Directors

Name
Position
Eugene Jiang
Chairman of the Board and Chief Business Officer
Che Wei Hsu
Independent Director
Hsin Hui Miao
Independent Director
Norimi Sakamoto
Independent Director
Tsung Shann Jiang
Chief Strategy Officer, Chief Scientific Officer and Director
Yen Hsin Chou
Independent Director
Yoshinobu Odaira
Independent Director
Yu Min Chung
Independent Director
Chang Jen Jiang
Director
Shuling Jiang
Director
Tsang Ming Jiang
Director

Shareholders

Name
Position
Uttam Patil
Chief Executive Officer
Leeds Chow
Chief Financial Officer
Eugene Jiang
Chairman of the Board and Chief Business Officer
Tsung Shann Jiang
Chief Strategy Officer, Chief Scientific Officer and Director